ArticleEuropean journal of pediatrics2026
Impact of depression on quality of life in PKU children.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Economic and Humanistic Burden of Phenylketonuria Among Patients and Their Caregivers: A Systematic Literature Review.PharmacoEconomics - open · 2026Pooled it
- Article
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phenylketonuria (PKU) is a hereditary metabolic disorder. It is characterized by the accumulation of phenylalanine (Phe) metabolites in the brain and body. These metabolites can harm brain function, especially cognition, if they are not reduced by following a Phe-restricted diet early in life. Despite early treatment with a Phe-restricted diet, many neuro-psychiatric disorders are still reported in adults with PKU. The aim of this study is to assess depression in children with PKU. The study included 76 children aged 8-15 years. They were divided into late-diagnosed, early-diagnosed, and healthy control groups. Participants completed the Birelson depression scale and Peds QL 4.0 to measure health-related quality of life. Phe levels were measured at testing and averaged from the previous year. Children with PKU have higher depression scores than healthy controls. Late-diagnosed children have higher depression scores than early-diagnosed children (p = 0.001). Early-diagnosed children differ from controls only in reduced activity (p = 0.004). Late-diagnosed children show more loss of energy (85.7%), irritability (78.6%), and suicidal thoughts (21.4%). Quality of life is lower in children with PKU compared to controls, either regarding the total score or all domains. Quality of life is negatively correlated to Phe levels and depression scores (r = - 0.32 and r = - 0.51, respectively) while positively correlated to IQ levels (r = 0.74).Conclusion: Children with PKU show more depression and lower quality of life. These effects may be linked to diagnosis timing, long term Phe control, and IQ. Depression is more pronounced in late-diagnosed children than in early-diagnosed ones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.